AI News NQ Analysis

NTUH's 'Histotripsy' Non-Invasive Cancer Treatment Reaches 80 Cases; Asia-Pacific's Only Training Center Inaugurated

NQ Score 0/100
N1 Content Completeness 9

AI Summary (NQ-processed)

National Taiwan University Hospital (NTUH) has introduced 'Histotripsy' technology, a non-invasive cancer treatment using focused ultrasound to destroy tumors without wounds. After 80 clinical trials in one year, NTUH signed an MOU with the US and inaugurated the Asia-Pacific Cancer Histotripsy Training Center, becoming the only medical center in the region with multi-cancer clinical trial experience.

AI Analysis

Frequently Asked Questions

Q: What types of cancer can histotripsy treat?
A: It is currently approved for liver tumors by the TFDA and FDA, but research is ongoing for other cancer types.
Q: What are the benefits of histotripsy treatment?
A: It requires no incisions or punctures, involves no thermal damage or radiation exposure, and allows for very quick recovery.
Q: Is histotripsy treatment covered by insurance?
A: It is currently a self-pay treatment, and the cost in Taiwan is expected to be less than half of that in Hong Kong.